[RECENT ARCHIVES] MIDLIFE MINI-19, Tuesday, September 12, 2023 - Seventy-Five (75) Years of [Baseless] Revenue is "Impressive."
"Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications stocked on store shelves."
Respectfully, like consumer zombies, many will keep taking it because they trusted the propaganda ... I mean ... the marketing ... I mean, the science ... cough, cough ... and the neural pathway is now set in compliant stone.
And if people stop taking it, what would happen to blood pressure medication sales?
Full excerpt:
"WASHINGTON (AP) — The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.
"Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications stocked on store shelves.
"'Modern studies, when well conducted, are not showing any improvement in congestion with phenylephrine,' said Dr. Mark Dykewicz, an allergy specialist at the Saint Louis University School of Medicine."
***
Pull it in 2007?
Nah, milk it for another sixteen (16) years, 2007-2023.
"This week’s two-day meeting was prompted by University of Florida researchers who petitioned the FDA to remove phenylephrine products based on recent studies showing they failed to outperform placebo pills in patients with cold and allergy congestion. The same researchers also challenged the drug’s effectiveness in 2007, but the FDA allowed the products to remain on the market pending additional research.
"That was also the recommendation of FDA's outside experts at the time, who met for a similar meeting on the drug in 2007.
"This time, the 16 members of the FDA panel unanimously agreed that current evidence doesn't show a benefit for the drug."
***
Then a revenue group ... I mean ... a trade group has argued to keep the money ... I mean ... the access flowing.
"A trade group representing nonprescription drugmakers, the Consumer Healthcare Products Association, argued that the new studies had limitations and that consumers should continue to have 'easy access' to phenylephrine."
***
Determined to have "no benefit," will it now be taken it off the market?
Nah ...
"There’s unlikely to be any immediate impact from Tuesday’s panel vote, which is not binding.
"The group’s negative opinion opens the door for the FDA to pull phenylephrine from a federal list of decongestants deemed effective for over-the-counter pills and liquids. The FDA said removing the products would eliminate 'unnecessary costs and delay in care of taking a drug that has no benefit.'
"The FDA's nasal decongestants drug list, or monograph, has not been updated since 1995. The process for changing a monograph has traditionally taken years or decades, requiring multiple rounds of review and public comment. But a 2020 law passed by Congress streamlines the process, which should allow the FDA to accelerate the publication of new standards, doses and labeling for nonprescription ingredients."
***
You might need to read this insanity twice.
Pulling the over-the-counter products off the market would ... wait for it, wait for it ... "likely force consumers to switch to the behind-the-counter pills or to nasal sprays and drops that contain phenylephrine, which are not under review." Meaning, higher dose products will still be prescribed and sold - literally - that also [likely] don't work.
"If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves. That would likely force consumers to switch to the behind-the-counter pills or to nasal sprays and drops that contain phenylephrine, which are not under review."
***
Seventy-five (75) years of [baseless] revenue "impressive."
- Matfucius
https://finance.yahoo.com/news/popular-nasal-decongestant-doesnt-actually-151429549.html
COMMENTS